Other Long Term Assets - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epizyme Inc
Other Long-Term Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Other Long-Term Assets
$17.4m
CAGR 3-Years
159%
CAGR 5-Years
90%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Long-Term Assets
$9.2B
CAGR 3-Years
24%
CAGR 5-Years
50%
CAGR 10-Years
28%
Gilead Sciences Inc
NASDAQ:GILD
Other Long-Term Assets
$4.4B
CAGR 3-Years
-8%
CAGR 5-Years
13%
CAGR 10-Years
18%
Amgen Inc
NASDAQ:AMGN
Other Long-Term Assets
$8.8B
CAGR 3-Years
15%
CAGR 5-Years
37%
CAGR 10-Years
19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Long-Term Assets
$3B
CAGR 3-Years
44%
CAGR 5-Years
15%
CAGR 10-Years
79%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Long-Term Assets
$3.9B
CAGR 3-Years
66%
CAGR 5-Years
32%
CAGR 10-Years
30%

See Also

What is Epizyme Inc's Other Long-Term Assets?
Other Long-Term Assets
17.4m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Other Long-Term Assets amounts to 17.4m USD.

What is Epizyme Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
90%

Over the last year, the Other Long-Term Assets growth was -4%. The average annual Other Long-Term Assets growth rates for Epizyme Inc have been 159% over the past three years , 90% over the past five years .

Back to Top